File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0025365724
- PMID: 2195318
- WOS: WOS:A1990DH64500008
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum
Title | Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum |
---|---|
Authors | |
Keywords | carcinoma drug resistance membrane |
Issue Date | 1990 |
Publisher | Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0300-8177 |
Citation | Molecular And Cellular Biochemistry, 1990, v. 95 n. 1, p. 61-70 How to Cite? |
Abstract | A membrane protein recognized by monoclonal antibody SQM1 was identified in human squamous carcinomas, including those originating in the head and neck (SqCHN), lung and cervix. Cell lines derived from SqCHN of previously untreated patients expressed high amounts of this protein. In contrast, many cell lines established from SqCHN of patients previously treated with chemotherapy and/or radiation showed diminished amounts of this SQM1 protein. The expression of SQM1 antigen was determined in several SqCHN cell lines made resistant by exposure to methotrexate (MTX) in vitro. The parent cell lines all exhibited strong binding to SQM1 antibody. The MTX-resistant sublines showed much lower membrane binding of SQM1. The lowest SQM1 reactivity was found in cell lines with high resistance to MTX and with dimineshed rate of MTX transport. Some highly MTX-resistant cell lines which had high levels of dihydrofolate reductase, but which retained a high rate of MTX transport, also retained high levels of SQM1 binding. Reduced SQM1 protein was also found in SqCHN cells which developed resistance to the alkylating drug cis-platinum (CDDP) and which showed reduced membrane transport of CDDP. Cell growth kinetics and non-specific antigenic shifts were not responsible for the differences in SQM1 binding between the parent cell lines and their drug-resistant sublines. The finding of a novel protein which is reduced in cell resistant to MTX and CDDP could contribute to our understanding of the basic mechanisms of drug resistance. By detecting SQM1 protein in clinical specimens, it may be possible to monitor the development of drug resistance in tumors. |
Persistent Identifier | http://hdl.handle.net/10722/149506 |
ISSN | 2023 Impact Factor: 3.5 2023 SCImago Journal Rankings: 0.901 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bernal, SD | en_US |
dc.contributor.author | Speak, JA | en_US |
dc.contributor.author | Boeheim, K | en_US |
dc.contributor.author | Dreyfuss, AI | en_US |
dc.contributor.author | Wright, JE | en_US |
dc.contributor.author | Teicher, BA | en_US |
dc.contributor.author | Rosowsky, A | en_US |
dc.contributor.author | Tsao, SW | en_US |
dc.contributor.author | Wong, YC | en_US |
dc.date.accessioned | 2012-06-26T05:54:38Z | - |
dc.date.available | 2012-06-26T05:54:38Z | - |
dc.date.issued | 1990 | en_US |
dc.identifier.citation | Molecular And Cellular Biochemistry, 1990, v. 95 n. 1, p. 61-70 | en_US |
dc.identifier.issn | 0300-8177 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/149506 | - |
dc.description.abstract | A membrane protein recognized by monoclonal antibody SQM1 was identified in human squamous carcinomas, including those originating in the head and neck (SqCHN), lung and cervix. Cell lines derived from SqCHN of previously untreated patients expressed high amounts of this protein. In contrast, many cell lines established from SqCHN of patients previously treated with chemotherapy and/or radiation showed diminished amounts of this SQM1 protein. The expression of SQM1 antigen was determined in several SqCHN cell lines made resistant by exposure to methotrexate (MTX) in vitro. The parent cell lines all exhibited strong binding to SQM1 antibody. The MTX-resistant sublines showed much lower membrane binding of SQM1. The lowest SQM1 reactivity was found in cell lines with high resistance to MTX and with dimineshed rate of MTX transport. Some highly MTX-resistant cell lines which had high levels of dihydrofolate reductase, but which retained a high rate of MTX transport, also retained high levels of SQM1 binding. Reduced SQM1 protein was also found in SqCHN cells which developed resistance to the alkylating drug cis-platinum (CDDP) and which showed reduced membrane transport of CDDP. Cell growth kinetics and non-specific antigenic shifts were not responsible for the differences in SQM1 binding between the parent cell lines and their drug-resistant sublines. The finding of a novel protein which is reduced in cell resistant to MTX and CDDP could contribute to our understanding of the basic mechanisms of drug resistance. By detecting SQM1 protein in clinical specimens, it may be possible to monitor the development of drug resistance in tumors. | en_US |
dc.language | eng | en_US |
dc.publisher | Springer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=0300-8177 | en_US |
dc.relation.ispartof | Molecular and Cellular Biochemistry | en_US |
dc.subject | carcinoma | - |
dc.subject | drug resistance | - |
dc.subject | membrane | - |
dc.subject.mesh | Antigens, Neoplasm - Analysis | en_US |
dc.subject.mesh | Carcinoma, Squamous Cell - Metabolism | en_US |
dc.subject.mesh | Cell Adhesion Molecules - Metabolism | en_US |
dc.subject.mesh | Cisplatin - Pharmacology | en_US |
dc.subject.mesh | Drug Resistance | en_US |
dc.subject.mesh | Fluorescent Antibody Technique | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Methotrexate - Pharmacology | en_US |
dc.subject.mesh | Nadh, Nadph Oxidoreductases | en_US |
dc.subject.mesh | Neoplasm Proteins - Metabolism | en_US |
dc.subject.mesh | Serpins | en_US |
dc.subject.mesh | Tumor Cells, Cultured | en_US |
dc.title | Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum | en_US |
dc.type | Article | en_US |
dc.identifier.email | Tsao, SW:gswtsao@hkucc.hku.hk | en_US |
dc.identifier.authority | Tsao, SW=rp00399 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 2195318 | - |
dc.identifier.scopus | eid_2-s2.0-0025365724 | en_US |
dc.identifier.volume | 95 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 61 | en_US |
dc.identifier.epage | 70 | en_US |
dc.identifier.isi | WOS:A1990DH64500008 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Bernal, SD=7006000150 | en_US |
dc.identifier.scopusauthorid | Speak, JA=6602867401 | en_US |
dc.identifier.scopusauthorid | Boeheim, K=6506573089 | en_US |
dc.identifier.scopusauthorid | Dreyfuss, AI=6602825553 | en_US |
dc.identifier.scopusauthorid | Wright, JE=7601524357 | en_US |
dc.identifier.scopusauthorid | Teicher, BA=7103270037 | en_US |
dc.identifier.scopusauthorid | Rosowsky, A=7102561915 | en_US |
dc.identifier.scopusauthorid | Tsao, SW=7102813116 | en_US |
dc.identifier.scopusauthorid | Wong, YC=7403041461 | en_US |
dc.identifier.issnl | 0300-8177 | - |